Search for: "Watson Laboratories"
Results 121 - 140
of 250
Sort by Relevance
|
Sort by Date
1 Dec 2011, 2:02 pm
(NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura(TM) (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz(R) oral contraceptive product. [read post]
5 Nov 2011, 4:17 am
In addition to Yaz and Yasmin the Washington Post identified these drosperinone-containing birth control pills: Bayer’s Beyaz and Safyral, Sandoz’s Syeda and Loryna, Barr Laboratories’ Ocella, Watson Pharmaceuticals’ Zarah, and Teva Pharmaceuticals’ Loryna. [read post]
1 Nov 2011, 6:08 am
Birth-control pills containing drospirenone include Bayer’s Yaz, Yasmin, Beyaz, Safyral; Sandoz’s Syeda and Loryna; Barr Laboratories’ Ocella; Watson Pharmaceuticals’ Zarah; and Teva Pharmaceuticals' Loryna. [read post]
29 Oct 2011, 5:51 am
The Eagle is the pub in which Watson and Crick hung out after hours from their work in nearby Cavendish Laboratory and where they made the announcement, commemorated by plaques within and without, of their discovery of the structure of DNA. [read post]
10 Oct 2011, 10:00 am
Three generic versions of the drug, manufactured and marketed by Teva, Cephalon/Watson Pharmaceuticals, and Covidien, currently exist in the United States; this number would be reduced to two after Teva's acquisition of Cephalon. [read post]
9 Oct 2011, 9:37 pm
• Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc.; Watson Pharma Inc.; Watson Laboratories Inc. - Florida Infringement of U.S. [read post]
30 Sep 2011, 2:32 pm
Barr Laboratories, Inc., 386 F.3d 485, 485 (2d Cir. 2004) [read post]
25 Aug 2011, 10:55 am
By James DeGiulio -- Allergan Secures Infringement Ruling Against Generics in Combigan Patent Suit Allergan has successfully secured an infringement ruling against Sandoz, Alcon, Apotex, and Watson Laboratories in the consolidated patent suit over four patents covering the glaucoma medication Combigan. [read post]
20 Aug 2011, 2:45 pm
" In Hamdard (Wakf) Laboratories v. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole) – US:… [read post]
18 Jul 2011, 5:16 pm
(“Cephalon”) on March 15, 2011 challenging FDA’s January 7, 2011 approval of Watson Laboratories, Inc. [read post]
17 Jul 2011, 9:17 pm
Watson Pharmaceuticals et al. 1:11-cv-00607; filed July 8, 2011 in the District Court of Delaware • Plaintiffs: Abbott Laboratories; Abbott Respiratory LLC • Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc. [read post]
15 Jul 2011, 11:32 pm
(IP Watch) (KEI) (Spicy IP) (GenericsWeb) Mucinex (Guaifenesin) – US: File history disclaimer dooms Reckitt Benckiser at CAFC: Reckitt Benckiser v Watson Laboratories / ?????? [read post]
15 Jul 2011, 11:32 pm
(IP Watch) (KEI) (Spicy IP) (GenericsWeb) Mucinex (Guaifenesin) – US: File history disclaimer dooms Reckitt Benckiser at CAFC: Reckitt Benckiser v Watson Laboratories / ?????? [read post]
13 Jul 2011, 3:04 am
Highlights this week included: Tenofovir, Emtricitabine, Elvitegravir, Cobicistat and combination product Quad – Global: Medicines Patent Pool boosts HIV drug prospects with first license (IP Watch) (KEI) (Spicy IP) (GenericsWeb) Mucinex (Guaifenesin) – US: File history disclaimer dooms Reckitt Benckiser at CAFC: Reckitt Benckiser v Watson Laboratories (IPBiz) (Patent Docs) (GenericsWeb) Multaq (Dronedarone) – Brazil: INPI did it again – pipeline… [read post]
11 Jul 2011, 9:59 pm
Watson Laboratories, Inc. - Florida, the Federal Circuit affirmed a decision by the District Court for the Southern District of Florida holding that Defendant-Appellee Watson Laboratories, Inc. - Florida did not infringe the asserted claims of U.S. [read post]
10 Jul 2011, 9:20 pm
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Laboratories, Inc. [read post]
8 Jul 2011, 1:13 pm
In 2009, Reckitt Benckiser Inc. sued Watson Laboratories, Inc. - Florida for patent infringement related to Watson's filing of three Abbreviated New Drug Applications for generic versions of Reckitt's Mucinex(R) line of products. [read post]
6 Jul 2011, 2:21 am
(2) (PatLit) Lidoderm (Lidocaine) – US: Delaware District Court decision in Endo Pharmaceuticals patent case favors Watson (GenericsWeb) Lidoderm (Lidocaine) – US: Endo files patent infringement suit against Watson in response to Para IV challenge (Patent Docs) Lipitor (Atorvastatin) – UK: English Patent Court grants temporary restraining order against Teva on short notice – Pfizer threatens pharmacies with legal action over generic Atorvastatin supply… [read post]
